13-30461417-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002128.7(HMGB1):āc.588T>Gā(p.Asp196Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,597,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002128.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGB1 | NM_002128.7 | c.588T>G | p.Asp196Glu | missense_variant | 5/5 | ENST00000341423.10 | NP_002119.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGB1 | ENST00000341423.10 | c.588T>G | p.Asp196Glu | missense_variant | 5/5 | 1 | NM_002128.7 | ENSP00000345347.5 |
Frequencies
GnomAD3 genomes AF: 0.0000599 AC: 9AN: 150344Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000198 AC: 3AN: 151632Hom.: 0 AF XY: 0.0000124 AC XY: 1AN XY: 80452
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1447366Hom.: 0 Cov.: 32 AF XY: 0.0000153 AC XY: 11AN XY: 719438
GnomAD4 genome AF: 0.0000599 AC: 9AN: 150344Hom.: 0 Cov.: 31 AF XY: 0.0000409 AC XY: 3AN XY: 73366
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.588T>G (p.D196E) alteration is located in exon 5 (coding exon 4) of the HMGB1 gene. This alteration results from a T to G substitution at nucleotide position 588, causing the aspartic acid (D) at amino acid position 196 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at